Hyaluronic acid also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues.
Market Analysis and Insights: Global and United States Medical Grade Hyaluronic Acid Market
This report focuses on global and United States Medical Grade Hyaluronic Acid market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Medical Grade Hyaluronic Acid market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Animal Tissue accounting for % of the Medical Grade Hyaluronic Acid global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Ophthalmology was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Medical Grade Hyaluronic Acid market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Medical Grade Hyaluronic Acid Scope and Market Size
Medical Grade Hyaluronic Acid market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Medical Grade Hyaluronic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Medical Grade Hyaluronic Acid market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Animal Tissue
Microbial Fermentation
Segment by Application
Ophthalmology
Joint Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Bloomage Biotech
Focus Chem
Fufeng Group
AWA Biopharm
China Eastar Group
Kewpie
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici